A potent anti-inflammatory compound, BC12, was identified in a PDE7 inhibitor HTS.
Inhibition of IL-2 induction occurs at the level of transcription.
A derivative of BC12 that lacks PDE7 inhibitory activity inhibits IL-2 induction.
BC12 and BC12-4 inhibit much of the inflammatory response in Jurkat T cells.
The anti-inflammatory action of these compounds is not via a loss of signaling.